Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APLANTUS: Apremilast in Moderate to Severe Palmoplantar Pustulosis
NCT04572997Phase 2Completed
- Start
- Nov 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apremilast in palmoplantar pustulosis (PPP). Started Nov 2018; status: completed.
02
Drugs
apremilast
03
Conditions
palmoplantar pustulosis (PPP)
Beyond the preview
Go deeper on NCT04572997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04572997.